Holocord Syringomyelia as the Dominant Feature in Noonan’s Syndrome

Publisher： Karger

E-ISSN： 1421-9913|44|3|181-182

ISSN： 0014-3022

Source： European Neurology, Vol.44, Iss.3, 2000-10, pp. : 181-182

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Related content

Noonan syndrome and related disorders: Alterations in growth and puberty

By Noonan Jacqueline  

Reviews in Endocrine and Metabolic Disorders, Vol. 7, Iss. 4, 2006-12 ,pp. : 251-255

Springer Publishing Company

Access to resources Recommend Favorite

The Role of Somatropin Therapy in Children with Noonan Syndrome

By Kelnar Chris J.H.  

Treatments in Endocrinology, Vol. 2, Iss. 3, 2003-01 ,pp. : 165-172

Adis International

Access to resources Recommend Favorite

Cerebral Occlusive Artery Disease in Noonan Syndrome

By  

Cerebrovascular Diseases, Vol. 14, Iss. 2, 2002-08 ,pp. : 133-135

Karger

Access to resources Recommend Favorite

A pseudo-dominant form of Gitelmans syndrome

By de La Faille Renaud   Vallet Marion   Venisse Annabelle   Nau Valrie   Collet-Gaudillat Carole   Houillier Pascal   Jeunemaitre Xavier   Vargas-Poussou Rosa  

NDT PLUS, Vol. 4, Iss. 6, 2011-12 ,pp. : 386-389

Oxford University Press

Access to resources Recommend Favorite

Syringes and Syringomyelia

By  

European Neurology, Vol. 54, Iss. 4, 2006-02 ,pp. : 243-243

Karger

Access to resources Recommend Favorite